Many studies, mostly conducted in Europe, demonstrate that raw milk consumption prevents children from developing allergies. Unfortunately, drinking raw milk is dangerous. A summary of these studies is attached below.
Researchers believe raw milk’s immune active proteins are largely responsible for the allergy prevention effect. These proteins have not been widely commercially available until now. TruActive™ provides these immune active proteins and is currently being tested in the following clinical trials to prove its ability to prevent children from developing allergies.
TruActive™ is currently being tested on asthmatic mice to determine if a therapeutic effect is observed. This study is occurring in Switzerland and started in January 2017.
An extensive study of TruActive™’s ability to reduce allergy development in children is planned by researchers at the University Hospital Munich. This 3,000 post-weaning infant study will investigate asthma, atopic dermatitis and food allergy development along with respiratory infections over a 5-year period after 3 years of TruActive™ consumption. The double blind, placebo controlled study is expected to start in early 2018.